Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: Does the Non-surgical Application of Enamel Matrix Derivative Reduce the Need of Periodontal Surgical Intervention in Subjects With Severe (Stage III) Periodontitis? [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether non-surgical application of enamel matrix derivative reduces the need for periodontal surgery in severe periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enamel Matrix Derivative (enamel matrix derivative)

Snippet

Sponsor: University of Pisa | Conditions: Periodontal Diseases | Phase 3 | Status: UNKNOWN